Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.69% | $25.59M | €346.61B | 38.28% | 78 Outperform | |
| AstraZeneca | 2.39% | $22.71M | $255.14B | 9.82% | 77 Outperform | |
| Rolls-Royce Holdings | 2.02% | $19.15M | £96.40B | 109.38% | 71 Outperform | |
| UniCredit SpA | 1.74% | $16.50M | €98.38B | 69.19% | 75 Outperform | |
| Unilever | 1.42% | $13.49M | £113.55B | -2.93% | 77 Outperform | |
| Siemens | 1.38% | $13.09M | €192.86B | 35.64% | 74 Outperform | |
| Sony | 1.30% | $12.38M | ¥26.73T | 67.49% | 74 Outperform | |
| Prosus | 1.30% | $12.32M | €133.31B | 61.66% | 77 Outperform | |
| SAP SE | 1.29% | $12.25M | €273.22B | 4.56% | 73 Outperform | |
| Roche Holding AG | 1.24% | $11.82M | CHF209.25B | 4.21% | 73 Outperform |